Surrey Heartlands

Joint Formulary & PAD

Guanfacine - Attention Deficit Hyperactivity Disorder (ADHD) - Adults

You are here : Home > Formulary Search > Guanfacine - Attention Deficit Hyperactivity Disorder (ADHD) - Adults

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :
  • Modified release tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Off Label
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Guanfacine
Indication :
Attention Deficit Hyperactivity Disorder (ADHD) - Adults
Group Name :
Keywords :
Brand Names Include :
Intuniv
Important Information :

Guanfacine for use in adult patients with ADHD (that have not transferred from children’s service on the medication), has not yet been assessed for formulary status.

National shared care documents are being considered by Surrey & Borders Partnership NHS Foundation Trust for implementation over the next few months through APC.

Adult patients currently being prescribed guanfacine in primary care can continue on treatment until they and their prescriber or specialist consider it appropriate to stop.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Guanfacine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Attention Deficit Hyperactivity Disorder (ADHD) - Adults.

Committee Recommendations (0)

  • No records returned.